151 related articles for article (PubMed ID: 37551918)
1. Treatment and mortality risk of older adults with non-small cell cancer in Taiwan: A population-based cohort study.
Wang CC; Chiu SW; Wu SJ; Pan LK; Yen YF; Lai YJ; Chen CC
Thorac Cancer; 2023 Sep; 14(26):2687-2695. PubMed ID: 37551918
[TBL] [Abstract][Full Text] [Related]
2. Effect of time interval from diagnosis to treatment for non-small cell lung cancer on survival: a national cohort study in Taiwan.
Tsai CH; Kung PT; Kuo WY; Tsai WC
BMJ Open; 2020 Apr; 10(4):e034351. PubMed ID: 32327476
[TBL] [Abstract][Full Text] [Related]
3. Patterns of care of nonsmall cell lung cancer patients in China and implications for survival.
He Y; Yu XQ; Luo Q; Xu X; Wang Y; Li S; Shan B
J Cancer Res Ther; 2018 Jun; 14(Supplement):S410-S415. PubMed ID: 29970698
[TBL] [Abstract][Full Text] [Related]
4. 30-day mortality after systemic anticancer treatment for breast and lung cancer in England: a population-based, observational study.
Wallington M; Saxon EB; Bomb M; Smittenaar R; Wickenden M; McPhail S; Rashbass J; Chao D; Dewar J; Talbot D; Peake M; Perren T; Wilson C; Dodwell D
Lancet Oncol; 2016 Sep; 17(9):1203-16. PubMed ID: 27599138
[TBL] [Abstract][Full Text] [Related]
5. Treatment Patterns and Overall Survival Associated with First-Line Systemic Therapy for Patients with Advanced Non-Small Cell Lung Cancer.
Spence MM; Hui RL; Chang JT; Schottinger JE; Millares M; Rashid N
J Manag Care Spec Pharm; 2017 Feb; 23(2):195-205. PubMed ID: 28125366
[TBL] [Abstract][Full Text] [Related]
6. Gefitinib or erlotinib in previously treated non-small-cell lung cancer patients: a cohort study in Taiwan.
Chang CH; Lee CH; Ko JC; Chang LY; Lee MC; Wang JY; Yu CJ
Cancer Med; 2017 Jul; 6(7):1563-1572. PubMed ID: 28639751
[TBL] [Abstract][Full Text] [Related]
7. Does timeliness of care in Non-Small Cell Lung Cancer impact on survival?
Vinod SK; Chandra A; Berthelsen A; Descallar J
Lung Cancer; 2017 Oct; 112():16-24. PubMed ID: 29191589
[TBL] [Abstract][Full Text] [Related]
8. Fasting plasma glucose is an independent predictor of survival in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy.
Bergamino M; Rullan AJ; Saigí M; Peiró I; Montanya E; Palmero R; Ruffinelli JC; Navarro A; Arnaiz MD; Brao I; Aso S; Padrones S; Cardenal F; Nadal E
BMC Cancer; 2019 Feb; 19(1):165. PubMed ID: 30791870
[TBL] [Abstract][Full Text] [Related]
9. The Refusal of Palliative Radiation in Metastatic Non-Small Cell Lung Cancer and Its Prognostic Implications.
Stavas MJ; Arneson KO; Ning MS; Attia AA; Phillips SE; Perkins SM; Shinohara ET
J Pain Symptom Manage; 2015 Jun; 49(6):1081-1087.e4. PubMed ID: 25596010
[TBL] [Abstract][Full Text] [Related]
10. Effects of multidisciplinary team care on the survival of patients with different stages of non-small cell lung cancer: a national cohort study.
Pan CC; Kung PT; Wang YH; Chang YC; Wang ST; Tsai WC
PLoS One; 2015; 10(5):e0126547. PubMed ID: 25966317
[TBL] [Abstract][Full Text] [Related]
11. Assessment of Tyrosine Kinase Inhibitors and Survival and Cardiovascular Outcomes of Patients With Non-Small Cell Lung Cancer in Taiwan.
Chang WT; Lin HW; Chang TC; Lin SH; Li YH
JAMA Netw Open; 2023 May; 6(5):e2313824. PubMed ID: 37195663
[TBL] [Abstract][Full Text] [Related]
12. Timeliness of Treatment Initiation and Associated Survival Following Diagnosis of Non-Small-Cell Lung Cancer in South Carolina.
Bullard JT; Eberth JM; Arrington AK; Adams SA; Cheng X; Salloum RG
South Med J; 2017 Feb; 110(2):107-113. PubMed ID: 28158880
[TBL] [Abstract][Full Text] [Related]
13. Guideline-concordant timely lung cancer care and prognosis among elderly patients in the United States: A population-based study.
Nadpara P; Madhavan SS; Tworek C
Cancer Epidemiol; 2015 Dec; 39(6):1136-44. PubMed ID: 26138902
[TBL] [Abstract][Full Text] [Related]
14. Trends in treatment and relative survival among Non-Small Cell Lung Cancer patients in the Netherlands (1990-2014): Disparities between younger and older patients.
Driessen EJ; Aarts MJ; Bootsma GP; van Loon JG; Janssen-Heijnen ML
Lung Cancer; 2017 Jun; 108():198-204. PubMed ID: 28625635
[TBL] [Abstract][Full Text] [Related]
15. Decreased Overall Survival in HIV-associated Non-small-cell Lung Cancer.
Hysell K; Yusuf R; Barakat L; Virata M; Gan G; Deng Y; Perez-Irizarry J; Vega T; Goldberg SB; Emu B
Clin Lung Cancer; 2021 Jul; 22(4):e498-e505. PubMed ID: 33468393
[TBL] [Abstract][Full Text] [Related]
16. Survival data in elderly patients with locally advanced non-small cell lung cancer.
Domingues PM; Zylberberg R; da Matta de Castro T; Baldotto CS; de Lima Araujo LH
Med Oncol; 2013 Mar; 30(1):449. PubMed ID: 23307257
[TBL] [Abstract][Full Text] [Related]
17. Hispanics/Latinos in the Bronx Have Improved Survival in Non-Small Cell Lung Cancer Compared with Non-Hispanic Whites.
Klugman M; Xue X; Ginsberg M; Cheng H; Rohan T; Hosgood HD
J Racial Ethn Health Disparities; 2020 Apr; 7(2):316-326. PubMed ID: 31713221
[TBL] [Abstract][Full Text] [Related]
18. The association of aspirin use with overall survival of patients with inoperable non-small cell lung cancer: a retrospective study.
Chuang MC; Yang YH; Hsieh MJ; Lin YC; Yang TM; Chen PC; Hung MS
BMC Cancer; 2021 Nov; 21(1):1257. PubMed ID: 34809588
[TBL] [Abstract][Full Text] [Related]
19. Distinctive characteristics of non-small cell lung cancer (NSCLC) in the young: a surveillance, epidemiology, and end results (SEER) analysis.
Subramanian J; Morgensztern D; Goodgame B; Baggstrom MQ; Gao F; Piccirillo J; Govindan R
J Thorac Oncol; 2010 Jan; 5(1):23-8. PubMed ID: 19934774
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant chemoradiation and surgery improves survival outcomes compared with definitive chemoradiation in the treatment of stage IIIA N2 non-small-cell lung cancer.
Darling GE; Li F; Patsios D; Massey C; Wallis AG; Coate L; Keshavjee S; Pierre A; De Perrot M; Yasufuku K; Cypel M; Waddell T
Eur J Cardiothorac Surg; 2015 Nov; 48(5):684-90; discussion 690. PubMed ID: 25567960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
